Subscribe

Main navigation

Home
Conferences
2026 Washington, DC
2026 London
2025 Berlin
2024 Athens
2023 New York City
CME
Spotlight
Studies
Media
About
About SEGM
FAQ
Our Response to the SPLC
Contact
Grant Opportunities
Support

Search results

Grant Funding Opportunities

July 20, 2026
Other

SEGM supports research that strengthens the evidence base in youth gender medicine through grant funding. We welcome proposals for:

Original researchSystematic reviews and meta-analysesEvidence synthesesOther scholarly work relevant to youth gender medicine

Previous Collaborations

...
Matched fragments:
… medicine Previous Collaborations Puberty Blockers for Gender Dysphoria in …

Gender dysphoria: scientific oversight falling between responsible institutions should worry us all

December 4, 2019
Studies
The troubles around the Gender Identity Development Service’s study12 seem to be symptomatic of our wider collective failure to determine whether, and when, we should prescribe puberty blockers, or cross sex hormones, to children and young people identifying as transgender. The ethics of research...
Matched fragments:
… and when, we should prescribe puberty blockers, or cross sex hormones, to …

A family consultation service for children with gender dysphoria: a brief intervention assessment model

January 2, 2026
Studies
Over the past 20 years, there has been a notable global rise in the number of children and adolescents presenting with gender identity issues, prompting significant shifts in clinical, social, and political discourse. In response to growing concerns about early medical intervention and the long-...
Matched fragments:
… and the long-term effects of puberty blockers and cross-sex hormones, the …

7. Hormonal Interventions for Gender Dysphoria in Minors: International Debate

September 11, 2025
CME | Course

What prompted European leaders in youth gender transition to pivot from widely used endocrine and surgical treatments to prioritizing psychological care? This course tackles the key debates surrounding gender-affirming hormone treatment for youth. Explore the ethical and clinical challenges...

Matched fragments:
… shaped Europe’s restrictions on puberty blockers and cross-sex hormones, …

How to improve research methodology in gender care: a non-binary choice

April 4, 2025
Studies

It is widely agreed that the evidence regarding the benefits and harms of the gender-affirming treatment (GAT) model for youth is inadequate. There is currently considerable discussion on how to improve the quality of this evidence. A recent paper by Van Breukelen provides a valuable...

Matched fragments:
… gender care model, specifically puberty blockers, easily culminate in a …

Commentary on Levine: A Tale of Two Informed Consent Processes

May 9, 2022
Studies
This commentary compares two recently published informed consent recommendations for gender dysphoria. One key difference identified is in their assessment of the strength of the evidence base for the gender affirming treatment model. An evaluation of both authors’ citations supports the claims of...
Matched fragments:
… weak evidence base for the use of puberty blockers and gender affirming …

Censorship of Essential Debate in Gender Medicine Research

October 27, 2025
Studies

In “Censorship of Essential Debate in Gender Medicine Research,” researcher J Cohn highlights serious publication integrity problems that plague the professional peer-reviewed literature in the field of gender medicine. Cohn argues that some medical journals are failing in their duty to ensure...

Matched fragments:
… gender intervention, that is, puberty blockers, hormones and/or surgeries, …

Gender Dysphoria in children and young people: The implications for clinical staff of the Bell V’s Tavistock Judicial Review and Appeal Ruling

December 9, 2021
Studies
In the past few years, there has been a very significant rise in the number of children and young people seeking treatment for gender dysphoria. This area is the subject of much discussion, as evidenced in a recent court case in the UK which examined competence and capacity of young people to...
Matched fragments:
… involved in gaining consent to puberty blockers for gender dysphoric young …

Gender-Related Care and Spending Among Youth in Medicaid and Children’s Health Insurance Program

April 1, 2026
Studies
About 3.3% of US adolescents aged 13 to 17 years identify as transgender and gender diverse (TGD). Gender-related medical care is defined here as hormone therapy (HT), puberty blockers, and surgical procedures. This study examines gender-related care (and associated spending) among youth between...
Matched fragments:
… here as hormone therapy (HT), puberty blockers, and surgical procedures. …

Mental health outcomes in transgender and nonbinary youths receiving gender-affirming care

February 25, 2022
Studies
Importance: Transgender and nonbinary (TNB) youths are disproportionately burdened by poor mental health outcomes owing to decreased social support and increased stigma and discrimination. Although gender-affirming care is associated with decreased long-term adverse mental health outcomes among...
Matched fragments:
… care and whether initiation of puberty blockers (PBs) and gender-affirming …

Pagination

  • First page « First
  • Previous page ‹
  • …
  • Page 10
  • Page 11
  • Page 12
  • Current page 13
  • Page 14
  • Next page ›
  • Last page Last »

SEGM is committed to safeguarding scientific integrity through open discourse and collaboration. Researchers and clinicians worldwide must be free to pursue scientific inquiry without censorship or intimidation.

Our Response to the SPLC
FAQs about SEGM
Close

Society for Evidence-Based Gender Medicine

© 2020-2026 SEGM